Merit Medical Systems (MM3) Financial Statements
Merit Medical Systems Financial Overview
Merit Medical Systems's market cap is currently $4.61B. The company's EPS TTM is $2.69; its P/E ratio is 32.06; Merit Medical Systems is scheduled to report earnings on February 24, 2027, and the estimated EPS forecast is $0.99. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.51B | $ 1.36B | $ 1.26B | $ 1.15B | $ 1.07B |
| Gross Profit | $ 736.94M | $ 643.33M | $ 583.87M | $ 519.10M | $ 485.33M |
| Operating Income | $ 184.38M | $ 155.69M | $ 123.94M | $ 87.56M | $ 60.92M |
| EBITDA | $ 332.05M | $ 273.97M | $ 228.89M | $ 181.17M | $ 154.96M |
| Net Income | $ 128.49M | $ 120.36M | $ 94.41M | $ 74.52M | $ 48.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 448.50M | $ 376.71M | $ 589.14M | $ 58.41M | $ 67.75M |
| Total Assets | $ 2.69B | $ 2.42B | $ 2.33B | $ 1.66B | $ 1.65B |
| Total Debt | $ 898.23M | $ 794.66M | $ 891.36M | $ 279.75M | $ 325.70M |
| Net Debt | $ 449.73M | $ 417.95M | $ 304.32M | $ 221.35M | $ 257.95M |
| Total Liabilities | $ 1.10B | $ 1.04B | $ 1.12B | $ 519.57M | $ 608.50M |
| Stockholders' Equity | $ 1.58B | $ 1.38B | $ 1.20B | $ 1.14B | $ 1.04B |
| Cash Flow | |||||
| Free Cash Flow | $ 212.53M | $ 182.76M | $ 108.45M | $ 69.26M | $ 119.29M |
| Operating Cash Flow | $ 297.37M | $ 220.80M | $ 145.15M | $ 114.29M | $ 147.23M |
| Investing Cash Flow | $ -247.39M | $ -368.65M | $ -175.35M | $ -57.40M | $ -37.16M |
| Financing Cash Flow | $ 16.00M | $ -60.01M | $ 559.27M | $ -60.26M | $ -98.44M |
Currency in USD